Original Article

Evaluation of Chronic Hepatitis C Patients from Different Aspects Before the Use of Direct Acting Antivirals
  • Sibel YILDIZ KAYA
  • Bilgül METE
  • Abdurrahman KAYA
  • Ilker Inanç BALKAN
  • Nese SALTOGLU
  • Fehmi TABAK
Viral Hepat J 2017; 23: 6-9 DOI: 10.4274/vhd.52724
Full
Text

Research Article

The Long-term (10.6 years) Outcome of Hepatitis C patients with Sustained Virologic Response Following Treatment with Pegylated Interferon + Ribavirin
  • Osman Özdoğan
  • Serkan Yaraş
Viral Hepat J 2020; 26: 22-27 DOI: 10.4274/vhd.galenos.2019.2019.0042
Full
Text
Effect of Advanced Fibrosis Presence on Adherence to Hepatocellular Carcinoma Surveillance in Chronic Hepatitis C Patients with Sustained Virologic Response
  • Göktuğ Şirin
  • Sadettin Hülagü
Viral Hepat J 2020; 26: 32-38 DOI: 10.4274/vhd.galenos.2020.2020.0002
Full
Text
Clinical Efficacy and Safety of Direct-Acting Antivirals in Chronic Hepatitis C Treatment: Real-World Data
  • Ayla Doğrugörün
  • Elif Doyuk Kartal
  • Saygın Nayman Alpat
Viral Hepat J 2023; 29: 95-100 DOI: 10.4274/vhd.galenos.2023.2023-6-1
Full
Text
Advanced Search

About Journal

Forms

Useful Links

Subscribe
Latest Update: 26.12.2023
2024 © Galenos Publishing House.